Related references
Note: Only part of the references are listed.Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer
Yanyan Zhu et al.
ONCOLOGY REPORTS (2016)
Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients
Fan Zhang et al.
ONCOLOGY LETTERS (2016)
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Phillip Stahl et al.
BMC GASTROENTEROLOGY (2015)
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
Michalina Janiszewska et al.
NATURE GENETICS (2015)
Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma
Yang-Kun Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
Asa Dahle-Smith et al.
MOLECULAR CYTOGENETICS (2015)
Recent advances in the HER2 targeted therapy of gastric cancer
Tasuku Matsuoka et al.
WORLD JOURNAL OF CLINICAL CASES (2015)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing
Dominique Werner et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
被撤回的出版物: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients (Retracted article. See vol. 20, 29, 2015)
Yushuang Luo et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2014)
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
M. A. Gordon et al.
ANNALS OF ONCOLOGY (2013)
HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
Diana P. English et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas
Sabina Berezowska et al.
PLOS ONE (2013)
ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
Yangkai Li et al.
PLOS ONE (2013)
Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients
Yoonjung Kim et al.
PLOS ONE (2013)
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome
G. Somlo et al.
ANNALS OF ONCOLOGY (2008)
Status of HER-2 gene amplification in breast cancers from Native American women
Lindsey D. Rieck et al.
CANCER GENETICS AND CYTOGENETICS (2008)